Printer Friendly

KitoZyme.

KitoZyme: appointed Francois Blondel as the new chief executive officer of the company. He was also appointed to the KitoZyme board of directors.

Prior to joining KitoZyme, Blondel has gained broad experience in the management of innovation driven companies. He started his career in the chemical and oil and gas sectors, with assignments both in the US and in Europe. In 1999, he joined International Brachytherapy (IBt), a startup in the medical device sector focused on cancer treatment. He served as CEO, leading IBt, a Euronext stock listed company, from its R&D stage to a successful and well-diversified international group and European leader in its sector.

Today, he is also serving as a board member of Compagnie du Bois Sauvage (diversified holding company listed on Euronext), Sopartec (holding of UCL university spinoffs), Nanocyl (world leader in production of carbon nanotubes), and a number of other companies active in the technology sector.
COPYRIGHT 2013 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Personnel Roundup
Publication:Household & Personal Products Industry
Date:Feb 1, 2013
Words:152
Previous Article:Murad Inc.
Next Article:Mintel.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters